Concentric Analgesics

Concentric Analgesics, Inc. is a private biotechnology company founded with the mission to develop novel, non-opioid therapeutics for managing acute and chronic pain. The company's vision is to provide effective pain relief solutions that reduce the reliance on opioids, thereby minimizing opioid-related adverse events. Concentric Analgesics focuses on creating TRPV1 agonist prodrugs that offer long-lasting pain relief through a single local administration. Their products are designed to be site-specific, simple to administer, and provide continuous and durable pain relief.

Notable affiliated people include experienced professionals from the biotechnology and pharmaceutical industries, contributing to the company's innovative approach. Concentric Analgesics has garnered attention from investors interested in non-opioid pain management solutions. Key achievements include the development of their lead product candidates and successful preclinical studies demonstrating efficacy and safety. Overall, Concentric Analgesics aims to significantly impact pain management practices by offering safer, non-opioid alternatives that improve patient outcomes and reduce the burden of opioid dependency.